"Development of an accessible and scalable qPCR assay for Monkeypox vir" by Abigail J. Porzucek, Abigale M. Proctor et al.
 

Development of an accessible and scalable qPCR assay for Monkeypox virus detection

Document Type

Journal Article

Publication Date

10-12-2022

Journal

The Journal of infectious diseases

DOI

10.1093/infdis/jiac414

Keywords

Monkeypox; PCR; diagnostics; emerging infectious disease; global health; outbreak response; qPCR assay

Abstract

During the 2022 monkeypox (MPX) outbreak, testing has been limited and results delayed, allowing ongoing transmission. Gold-standard qPCR diagnostics are difficult to obtain. This research adapted the June 2022 CDC MPX qPCR assay for broad implementation. Validated using MPX stocks in a matrix with multiple sample types, MPX was detected with Cq values of 17.46 to 35.59 and titer equivalents 8.01 × 106 to 2.45 × 100 PFU/mL. The detection limit was 3.59 PFU/mL. Sensitivity and specificity were both 100%. This qPCR assay can be quickly and broadly implemented in research and public health labs to increase diagnostic capacity amid the growing MPX outbreak.

Department

Global Health

Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 7
  • Usage
    • Abstract Views: 14
  • Captures
    • Readers: 26
  • Mentions
    • News Mentions: 1
see details

Share

COinS